Indonesia has received 3 million doses of Sinovac's CoronaVac. - Reuters
JAKARTA (The Straits Times/ANN): Indonesian food and drug monitoring agency (BPOM) on Monday (Jan 11) issued emergency use authorisation for the vaccine developed by China's Sinovac Biotech, after a local clinical trial found it is 65.3 per cent effective against the coronavirus.
This paves the way for the world's fourth-most populous country, which is the worst hit by the pandemic in South-east Asia, to roll out its vaccination programme across its 34 provinces starting on Thursday (Jan 14).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
